Target intelligence / Profile preview

Streptococcal M protein Emm55 (Emm55)

Target
Emm55
Molecular classification
Surface protein, Virulence factor
01

Overview

The Streptococcal M protein Emm55 is a surface-exposed, fibrillar coiled-coil dimer on Group A Streptococcus (GAS) that extends from the bacterial cell wall, serving as a major virulence factor. It inhibits phagocytosis by binding host proteins like fibrinogen, IgG, and plasminogen (including via an S-region motif shared with M1 and M64), promotes adherence to epithelial cells, and aids in overcoming innate immunity through interactions along its length. Emm55 belongs to an emm-type classification, where its N-terminal sequence defines strain typing (emm-typing by CDC) among over 275 identified types. The full protein structure is highly predictive from this N-terminal region, showing high conservation (88-100% identity) within its specific emm-type, though lengths can vary significantly across different emm patterns (e.g., A-C being longest, E shortest). Structural features include heptad repeats stabilizing the coiled coil, contributing to its functionality. In disease, Emm55 drives GAS pathogenesis in infections ranging from pharyngitis to invasive disease, with emm-types like Emm55 correlating to specific emm patterns (e.g., potentially D or E) linked to tissue tropism and epidemiology. While Emm55 is a key vaccine antigen target, its extensive sequence diversity across hundreds of emm-types poses significant challenges for developing broadly protective vaccines. No approved therapeutics directly target Emm55; rather, vaccine development focuses on leveraging M protein conservation.

Other names
M55 proteinEmm55 M protein
02

Biological functions

Inhibits phagocytosisPromotes adherence to host epithelial cellsBinds host proteins (e.g., fibrinogen, IgG, plasminogen)Immune evasion
03

Disease associations

Infection (Group A Streptococcus infections, including invasive disease)
04

Safety considerations

Antigenic diversity may complicate vaccine efficacyPotential for autoimmunity from cross-reactivity with host tissues

Beyond the preview

Go deeper on Streptococcal M protein Emm55 (Emm55).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcal M protein Emm55 (Emm55).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call